Bio-Path Holdings Inc. (BPTH)

1.61
0.05 3.10
NASDAQ : Health Technology
Prev Close 1.66
Open 1.74
Day Low/High 1.55 / 1.74
52 Wk Low/High 1.53 / 10.10
Volume 52.89K
Avg Volume 753.50K
Exchange NASDAQ
Shares Outstanding 11.34M
Market Cap 17.92M
EPS -0.70
Div & Yield N.A. (N.A)

Latest News

Bio-Path Holdings Reports Third Quarter 2017 Financial Results

Bio-Path Holdings Reports Third Quarter 2017 Financial Results

Conference Call to be Held Tomorrow at 8:30 A.M. ET

Bio-Path Holdings Highlights Advancements In Preclinical Discovery Efforts

Bio-Path Holdings Highlights Advancements In Preclinical Discovery Efforts

Selects New Drug Compound, BP1003, for Treatment of Pancreatic Cancer

Bio-Path Holdings Reports Second Quarter 2017 Financial Results

Bio-Path Holdings Reports Second Quarter 2017 Financial Results

Conference Call to be Held Today at 8:30 A.M. ET

Bio-Path Holdings Receives Notice Of Allowance For Key U.S. Composition Of Matter Patent

Bio-Path Holdings Receives Notice Of Allowance For Key U.S. Composition Of Matter Patent

Further Protects Company's Proprietary Liposomal Delivery and Antisense Technology

Bio-Path Holdings Reports First Quarter 2017 Financial Results

Conference Call to be Held Today at 8:30 A.M. ET

Bio-Path Holdings Presents Results Showing Potential Of BP1002 As Treatment For Aggressive Non-Hodgkin's Lymphoma

- In Vivo and Preclinical Data Presented at AACR Annual Meeting -

Bio-Path Holdings Reports Full Year 2016 Financial Results

Conference Call to be Held Today at 8:30 A.M. ET

Bio-Path Holdings Appoints Dr. Craig Hooper To Scientific Advisory Board

Renowned neuroimmunology researcher joins SAB to advance DNAbilize™ technology in glioblastoma

Short Interest In Bio-Path Holdings Expands By 23.3%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 544,221 share increase in total short interest for Bio-Path Holdings, Inc. , to 2,876,240, an increase of 23.34% since 01/13/2017.

Bio-Path Holdings Reports Third Quarter 2016 Financial Results

Bio-Path Holdings Reports Third Quarter 2016 Financial Results

Conference Call to be Held Today at 8:30 A.M. ET